These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 30204533)
1. Identification of G-Quadruplex-Binding Inhibitors of Myc Expression through Affinity Selection-Mass Spectrometry. Flusberg DA; Rizvi NF; Kutilek V; Andrews C; Saradjian P; Chamberlin C; Curran P; Swalm B; Kattar S; Smith GF; Dandliker P; Nickbarg EB; O'Neil J SLAS Discov; 2019 Feb; 24(2):142-157. PubMed ID: 30204533 [TBL] [Abstract][Full Text] [Related]
2. Small Molecule Microarrays Enable the Identification of a Selective, Quadruplex-Binding Inhibitor of MYC Expression. Felsenstein KM; Saunders LB; Simmons JK; Leon E; Calabrese DR; Zhang S; Michalowski A; Gareiss P; Mock BA; Schneekloth JS ACS Chem Biol; 2016 Jan; 11(1):139-48. PubMed ID: 26462961 [TBL] [Abstract][Full Text] [Related]
3. Discovery of a fluorescent, long chain-bridged bispurine that selectively targets the c-MYC G-quadruplex. Hu MH; Lin JH; Huang Q Bioorg Chem; 2022 May; 122():105750. PubMed ID: 35325695 [TBL] [Abstract][Full Text] [Related]
5. Phenanthroline-bis-oxazole ligands for binding and stabilization of G-quadruplexes. Medeiros-Silva J; Guédin A; Salgado GF; Mergny JL; Queiroz JA; Cabrita EJ; Cruz C Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1281-1292. PubMed ID: 27865994 [TBL] [Abstract][Full Text] [Related]
6. Development of a fluorescent ligand that specifically binds to the c-MYC G-quadruplex by migrating the benzene group on a carbazole-benzothiazolium scaffold. Wang R; Hu MH Bioorg Chem; 2024 Oct; 151():107690. PubMed ID: 39098087 [TBL] [Abstract][Full Text] [Related]
7. [Determination of the binding of natural products to the human c-myb oncogene promoter G-quadruplex DNA by capillary electrophoresis and electrospray ionization mass spectrometry]. Wang S; Yang Y; Fan S; Li H; David DYC Se Pu; 2020 Sep; 38(9):1069-1077. PubMed ID: 34213273 [TBL] [Abstract][Full Text] [Related]
8. Chemical and structural studies provide a mechanistic basis for recognition of the MYC G-quadruplex. Calabrese DR; Chen X; Leon EC; Gaikwad SM; Phyo Z; Hewitt WM; Alden S; Hilimire TA; He F; Michalowski AM; Simmons JK; Saunders LB; Zhang S; Connors D; Walters KJ; Mock BA; Schneekloth JS Nat Commun; 2018 Oct; 9(1):4229. PubMed ID: 30315240 [TBL] [Abstract][Full Text] [Related]
10. A short peptide that preferentially binds c-MYC G-quadruplex DNA. Minard A; Morgan D; Raguseo F; Di Porzio A; Liano D; Jamieson AG; Di Antonio M Chem Commun (Camb); 2020 Aug; 56(63):8940-8943. PubMed ID: 32638724 [TBL] [Abstract][Full Text] [Related]
11. Human MYC G-quadruplex: From discovery to a cancer therapeutic target. Wang W; Hu S; Gu Y; Yan Y; Stovall DB; Li D; Sui G Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188410. PubMed ID: 32827579 [TBL] [Abstract][Full Text] [Related]
12. Custom G4 Microarrays Reveal Selective G-Quadruplex Recognition of Small Molecule BMVC: A Large-Scale Assessment of Ligand Binding Selectivity. Wu G; Tillo D; Ray S; Chang TC; Schneekloth JS; Vinson C; Yang D Molecules; 2020 Jul; 25(15):. PubMed ID: 32751510 [TBL] [Abstract][Full Text] [Related]
13. Targeting specific DNA G-quadruplexes with CRISPR-guided G-quadruplex-binding proteins and ligands. Qin G; Liu Z; Yang J; Liao X; Zhao C; Ren J; Qu X Nat Cell Biol; 2024 Jul; 26(7):1212-1224. PubMed ID: 38961283 [TBL] [Abstract][Full Text] [Related]
14. Solution structures and effects of a platinum compound successively bound MYC G-quadruplex. Liu W; Zhu BC; Liu LY; Xia XY; Jang J; Dickerhoff J; Yang D; Mao ZW Nucleic Acids Res; 2024 Sep; 52(16):9397-9406. PubMed ID: 39077944 [TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of nucleolin as a c-myc G-quadruplex-binding protein. González V; Guo K; Hurley L; Sun D J Biol Chem; 2009 Aug; 284(35):23622-35. PubMed ID: 19581307 [TBL] [Abstract][Full Text] [Related]
16. Constructing triazole-modified quinazoline derivatives as selective c-MYC G-quadruplex ligands and potent anticancer agents through click chemistry. Cai JH; Yang DY; Zhang JJ; Tan JH; Huang ZS; Chen SB Bioorg Chem; 2024 Mar; 144():107173. PubMed ID: 38335759 [TBL] [Abstract][Full Text] [Related]
17. New substituted quinoxalines inhibit triple-negative breast cancer by specifically downregulating the c-MYC transcription. Hu MH; Wu TY; Huang Q; Jin G Nucleic Acids Res; 2019 Nov; 47(20):10529-10542. PubMed ID: 31584090 [TBL] [Abstract][Full Text] [Related]
18. Targeted Downregulation of MYC through G-quadruplex Stabilization by DNAi. Psaras AM; Chang KT; Hao T; Brooks TA Molecules; 2021 Sep; 26(18):. PubMed ID: 34577013 [TBL] [Abstract][Full Text] [Related]
19. DDX5 helicase resolves G-quadruplex and is involved in Wu G; Xing Z; Tran EJ; Yang D Proc Natl Acad Sci U S A; 2019 Oct; 116(41):20453-20461. PubMed ID: 31548374 [TBL] [Abstract][Full Text] [Related]
20. Structural recognition of the MYC promoter G-quadruplex by a quinoline derivative: insights into molecular targeting of parallel G-quadruplexes. Dickerhoff J; Dai J; Yang D Nucleic Acids Res; 2021 Jun; 49(10):5905-5915. PubMed ID: 33978746 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]